Cited by 148Pulmonary Hypertension Research and TreatmentsTelomeres, Telomerase, and SenescenceSystemic Sclerosis and Related Diseases

Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression

Born, Emmanuelle, Lipskaia, Larissa, Breau, Marielle, Houssaini, Amal, Beaulieu, Delphine, Marcos, Elisabeth, Pierre, Remi, Do Cruzeiro, Marcio +11 more·2023·Circulation

Abstract

Background: Senescent cells (SCs) are involved in proliferative disorders, but their role in pulmonary hypertension remains undefined. We investigated SCs in patients with pulmonary arterial hypertension and the role of SCs in animal pulmonary hypertension models. Methods: We investigated senescence (p16, p21) and DNA damage (γ-H2AX, 53BP1) markers in patients with pulmonary arterial hypertension and murine models. We monitored p16 activation by luminescence imaging in p16-luciferase (p16 LUC/+ ) knock-in mice. SC clearance was obtained by a suicide gene (p16 promoter–driven killer gene construct in p16-ATTAC mice), senolytic drugs (ABT263 and cell-permeable FOXO4-p53 interfering peptide [FOXO4-DRI]), and p16 inactivation in p16 LUC/LUC mice. We investigated pulmonary hypertension in mice exposed to normoxia, chronic hypoxia, or hypoxia+Sugen, mice overexpressing the serotonin transporter (SM22-5-HTT + ), and rats given monocrotaline. Results: Patients with pulmonary arterial hypertension compared with controls exhibited high lung p16, p21, and γ-H2AX protein levels, with abundant vascular cells costained for p16, γ-H2AX, and 53BP1. Hypoxia increased thoracic bioluminescence in p16 LUC/+ mice. In wild-type mice, hypoxia increased lung levels of senescence and DNA-damage markers, senescence-associated secretory phenotype components, and p16 staining of pulmonary endothelial cells (P-ECs, 30% of lung SCs in normoxia), and pulmonary artery smooth muscle cells. SC elimination by suicide gene or ABT263 increased the right ventricular systolic pressure and hypertrophy index, increased vessel remodeling (higher dividing proliferating cell nuclear antigen–stained vascular cell counts during both normoxia and hypoxia), and markedly decreased lung P-ECs. Pulmonary hemodynamic alterations and lung P-EC loss occurred in older p16 LUC/LUC mice, wild-type mice exposed to Sugen or hypoxia+Sugen, and SM22-5-HTT + mice given either ABT263 or FOXO4-DRI, compared with relevant controls. The severity of monocrotaline-induced pulmonary hypertension in rats was decreased slightly by ABT263 for 1 week but was aggravated at 3 weeks, with loss of P-ECs. Conclusions: Elimination of senescent P-ECs by senolytic interventions may worsen pulmonary hemodynamics. These results invite consideration of the potential impact on pulmonary vessels of strategies aimed at controlling cell senescence in various contexts.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.122.058794

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Senescent cells have important physiological roles and their clearance may be detrimental in certain conditions.

    “It should be noted, however, that senescent cells also have important physiological roles and that their clearance may be detrimental in certain conditions3–5.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Born, E., Lipskaia, L., Breau, M., Houssaini, A., Beaulieu, D., Marcos, E., Pierre, R., Do Cruzeiro, M., Lefevre, M., Derumeaux, G., Bulavin, D. V., Delcroix, M., Quarck, R., Reen, V., Gil, J., Bernard, D., Flaman, J.-M., Adnot, S., & Abid, S.
Affiliations
  • Inserm (FR)
  • Centre National de la Recherche Scientifique (FR)
  • INSERM U955 and Département de Physiologie, Hôpital Henri Mondor, FHU SENEC, AP-HP, Créteil, France; Université Paris-Est Créteil (UPEC), France (E.B., L.L., M.B., A.H., D.P.B., E.M., G.D., S. Adnot, S. Abid).
  • Plate-forme de Recombinaison Homologue, Institut Cochin, INSERM, Paris, France (R.P., M.D.-C.).
  • Institut Mutualiste Montsouris, Département anatomopathologie, Paris, France (M.L.).
  • Institut de Recherche sur le Cancer et le Vieillissement de Nice (FR)
  • KU Leuven (BE)
  • MRC London Institute of Medical Sciences (GB)
  • MRC London Institute of Medical Sciences (LMS), United Kingdom (V.R., J.G.).
  • Liaquat University of Medical & Health Sciences (PK)
Corresponding author
  • Born, Emmanuelle
  • Lipskaia, Larissa
  • Breau, Marielle
Venue
Circulation
Published
2023-02-21
Volume
147
Issue
8
Pages
650-666
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W4311392380
Cited by
148
References
45
Citations by year
2026: 38 · 2025: 48 · 2024: 42 · 2023: 20
FWCI
17.89
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Lirias (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
Agence Nationale de la Recherche (ANR-20-CE14-0023, ANR-18-CE14-0031)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
Keywords
senescent cells, pulmonary arterial hypertension, senolytics, navitoclax, senescence-associated secretory phenotype, p16, p21, DNA damage, hypoxia, senolytic therapy, vascular endothelial cells, pulmonary artery smooth muscle cells, monocrotaline, serotonin transporter, right ventricular systolic pressure, vascular remodeling
MeSH terms
Pulmonary Arterial Hypertension, Senotherapeutics, Aniline Compounds, Animals, Hypoxia, Hypertension, Pulmonary, Pulmonary Artery, Sulfonamides, Monocrotaline, Cellular Senescence, Endothelial Cells, Mice, Rats, Forkhead Transcription Factors, Familial Primary Pulmonary Hypertension

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review